| 000 | 01836 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516201148.0 | ||
| 264 | 0 | _c20141215 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1553-7404 | ||
| 024 | 7 |
_a10.1371/journal.pgen.1004201 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBjörkegren, Johan L M | |
| 245 | 0 | 0 |
_aPlasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis. _h[electronic resource] |
| 260 |
_bPLoS genetics _cFeb 2014 |
||
| 300 |
_ae1004201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 |
_aApolipoproteins B _xgenetics |
| 650 | 0 | 4 |
_aAtherosclerosis _xblood |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHistone-Lysine N-Methyltransferase _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNuclear Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aReceptors, LDL _xgenetics |
| 650 | 0 | 4 |
_aRibonucleoproteins _xbiosynthesis |
| 650 | 0 | 4 | _aSerine-Arginine Splicing Factors |
| 700 | 1 | _aHägg, Sara | |
| 700 | 1 | _aTalukdar, Husain A | |
| 700 | 1 | _aForoughi Asl, Hassan | |
| 700 | 1 | _aJain, Rajeev K | |
| 700 | 1 | _aCedergren, Cecilia | |
| 700 | 1 | _aShang, Ming-Mei | |
| 700 | 1 | _aRossignoli, Aránzazu | |
| 700 | 1 | _aTakolander, Rabbe | |
| 700 | 1 | _aMelander, Olle | |
| 700 | 1 | _aHamsten, Anders | |
| 700 | 1 | _aMichoel, Tom | |
| 700 | 1 | _aSkogsberg, Josefin | |
| 773 | 0 |
_tPLoS genetics _gvol. 10 _gno. 2 _gp. e1004201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pgen.1004201 _zAvailable from publisher's website |
| 999 |
_c23601094 _d23601094 |
||